Waldencast plc

Contributing Author

Recent Articles by Waldencast plc

Jan-21	Obagi Medical Unveils ALOHA Program to Launch Obagi saypha MagIQ - Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler WALD GlobeNewswire
Nov-24	Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update WALD GlobeNewswire
Nov-16	Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting WALD GlobeNewswire
Nov-14	Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities WALD GlobeNewswire
Nov-12	Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates WALD GlobeNewswire
Oct-08	Obagi Medical Launches Nu-Cil BioStim Scalp Serum WALD GlobeNewswire
Sep-10	Waldencast Announces FDA Approval of Obagi saypha MagIQ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand WALD GlobeNewswire
Aug-18	Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation WALD GlobeNewswire
Jul-23	Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha, Under the Obagi Medical Brand WALD GlobeNewswire
May-13	Waldencast Reports Q1 2025 Financial Results WALD GlobeNewswire
May-06	Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast WALD GlobeNewswire